Alpha Cognition Inc
ACOG5.230USD
+0.170+3.36%
Cierre 04/25, 16:00（ET）Cotizaciones retrasadas 15 min
83.78MCap. mercado
PérdidaP/E TTM
Más Datos de Alpha Cognition Inc Compañía
Alpha Cognition Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company’s pipeline includes ALPHA-1062, ALPHA-0602, and ALPHA-0702 and ALPHA-0802 (GEMs). The Company’s ALPHA-1062 is a patented new chemical entity being developed as a new generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, with expected minimal gastrointestinal side effects. ALPHA-1062 is also being developed in combination with memantine to treat moderate to severe Alzheimer’s dementia, and as an intranasal formulation for Cognitive Impairment with mTBI. ALPHA-0602 is a gene therapy program delivering progranulin, a neurotrophic protein. It is in preclinical development for the treatment of ALS.
Información de la empresa
Código de la empresaACOG
Nombre de la empresaAlpha Cognition Inc
Fecha de salida a bolsaJun 09, 2021
Fundada en2017
Director ejecutivoMr. Michael Mcfadden
Número de empleados52
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 09
Direcciónc/o 1200 - 750 West Pender Street
CiudadVANCOUVER
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísCanada
Código postalV6C 2T8
Teléfono16045649244
Sitio Webhttps://www.alphacognition.com/
Código de la empresaACOG
Fecha de salida a bolsaJun 09, 2021
Fundada en2017
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Len Mertz
Mr. Len Mertz
Independent Chairman of the Board
Independent Chairman of the Board
223.53K
+2.40K%
Mr. Michael Mcfadden
Mr. Michael Mcfadden
Chief Executive Officer, Director
Chief Executive Officer, Director
11.53K
+2.40K%
Dr. Robert Wills
Dr. Robert Wills
Independent Director
Independent Director
--
--
Mr. Henry Du
Mr. Henry Du
Interim Chief Financial Officer, Vice President - Finance and Accounting
Interim Chief Financial Officer, Vice President - Finance and Accounting
--
--
Ms. Lauren D'Angelo
Ms. Lauren D'Angelo
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Kenneth A. (Ken) Cawkell
Mr. Kenneth A. (Ken) Cawkell
Corporate Secretary, Director
Corporate Secretary, Director
--
--
Mr. Rajeev (Rob) Bakshi
Mr. Rajeev (Rob) Bakshi
Independent Director
Independent Director
--
--
Mr. John Havens
Mr. John Havens
Independent Director
Independent Director
--
--
Mr. Phillip Mertz
Mr. Phillip Mertz
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Len Mertz
Mr. Len Mertz
Independent Chairman of the Board
Independent Chairman of the Board
223.53K
+2.40K%
Mr. Michael Mcfadden
Mr. Michael Mcfadden
Chief Executive Officer, Director
Chief Executive Officer, Director
11.53K
+2.40K%
Dr. Robert Wills
Dr. Robert Wills
Independent Director
Independent Director
--
--
Mr. Henry Du
Mr. Henry Du
Interim Chief Financial Officer, Vice President - Finance and Accounting
Interim Chief Financial Officer, Vice President - Finance and Accounting
--
--
Ms. Lauren D'Angelo
Ms. Lauren D'Angelo
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Kenneth A. (Ken) Cawkell
Mr. Kenneth A. (Ken) Cawkell
Corporate Secretary, Director
Corporate Secretary, Director
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Accionista
Hora de actualización: jue., 24 de abr
Hora de actualización: jue., 24 de abr
Estadísticas de accionistas
Tipo
Estadísticas de accionistas
Accionista
Proporción
Solas Capital Management, LLC
8.70%
AWM Investment Company, Inc.
6.58%
Cable Car Capital LLC
5.42%
Ikarian Capital LLC
4.72%
Sphera Funds Management Ltd.
3.87%
Other
70.72%
Estadísticas de accionistas
Accionista
Proporción
Solas Capital Management, LLC
8.70%
AWM Investment Company, Inc.
6.58%
Cable Car Capital LLC
5.42%
Ikarian Capital LLC
4.72%
Sphera Funds Management Ltd.
3.87%
Other
70.72%
Tipo
Accionista
Proporción
Hedge Fund
31.49%
Investment Advisor/Hedge Fund
15.07%
Individual Investor
8.21%
Investment Advisor
2.23%
Corporation
1.38%
Bank and Trust
0.07%
Other
41.54%
Participación institucional
Hora de actualización: mar., 1 de abr
Hora de actualización: mar., 1 de abr
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
35
8.65M
54.08%
+8.55M
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Solas Capital Management, LLC
1.39M
8.7%
+1.39M
--
Dec 31, 2024
AWM Investment Company, Inc.
1.05M
6.58%
+1.05M
--
Dec 31, 2024
Cable Car Capital LLC
514.72K
3.21%
+514.72K
--
Dec 31, 2024
Ikarian Capital LLC
755.87K
4.72%
+755.87K
--
Dec 31, 2024
Sphera Funds Management Ltd.
620.00K
3.87%
+620.00K
--
Dec 31, 2024
Sio Capital Management, LLC
434.70K
2.71%
+434.70K
--
Dec 31, 2024
Alyeska Investment Group, L.P.
400.00K
2.5%
+400.00K
--
Dec 31, 2024
Manchester Management Company, L.L.C.
379.34K
2.37%
+364.17K
+2.40K%
Nov 13, 2024
Havens (John P)
285.59K
1.78%
+274.34K
+2.44K%
Nov 13, 2024
Altium Capital Management LP
275.00K
1.72%
+275.00K
--
Dec 31, 2024
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos